136 related articles for article (PubMed ID: 12530050)
1. Application of cisplatin as intraoperative hyperthermic peritoneal lavage (IHPL) in patients with locally advanced gastric cancer: analysis of pharmacokinetics and of nephrotoxicity.
Kern W; Braess J; Kotschofsky M; Samel S; Becker H; Hiddemann W; Schleyer E
Anticancer Res; 2002; 22(5):3099-102. PubMed ID: 12530050
[TBL] [Abstract][Full Text] [Related]
2. [Total body hyperthermia and continuous hyperthermic peritoneal perfusion as an adjuvant therapy in advanced gastric cancer].
Sugiyama Y; Suzuki H; Hada R; Miyagishima K; Yokoyama M; Daidouji K; Murata A; Yamazaki S; Mikami Y; Ozawa M
Gan To Kagaku Ryoho; 1991 Apr; 18(4):619-24. PubMed ID: 1901477
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between plasma and urinary platinum pharmacokinetics with cisplatin nephrotoxicity in breast cancer patients].
Guo JH
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):150-3. PubMed ID: 1618086
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.
Egorin MJ; Van Echo DA; Tipping SJ; Olman EA; Whitacre MY; Thompson BW; Aisner J
Cancer Res; 1984 Nov; 44(11):5432-8. PubMed ID: 6386150
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the appropriate administration of cisplatin based on pharmacokinetics and toxicity].
Kitajima K; Fukuoka M; Kobayashi S; Kusunoki Y; Takada M; Negoro S; Matsui K; Sakai N; Ryu S; Takifuji N
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2517-23. PubMed ID: 3039920
[TBL] [Abstract][Full Text] [Related]
6. [Intraperitoneal administration of anti-cancer drug with cisplatinum (CDDP)].
Hirahata S; Kumai K; Hurukawa T; Shimada A; Shibata S; Aizawa K; Matsui H; Takahara T; Shimizu H; Hukase T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1555-60. PubMed ID: 2389948
[TBL] [Abstract][Full Text] [Related]
7. [Continuous hyperthermic peritoneal perfusion (CHPP) therapy in advanced gastric cancer].
Suzuki H; Miyagishima K; Gasa F; Hakamada K; Seino K; Hada R; Mikami Y; Sugiyama Y; Konn M; Ono K
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1769-72. PubMed ID: 1908652
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic analysis in intraperitoneal hyperthermic perfusion using mitomycin C in far-advanced gastric cancer].
Fujimoto S; Shrestha RD; Kokubun M; Kobayashi K; Kiuchi S; Ohta M; Takahashi M; Konno C; Koike S; Okui K
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2411-5. PubMed ID: 2502075
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetic study of intraperitoneal cisplatin chemotherapy for gastric cancer as an adjuvant setting].
Kochi M; Fujii M; Takano S; Kato Y; Kawakami T; Kanamori N; Iwai S; Tanaka T
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1535-7. PubMed ID: 7574752
[TBL] [Abstract][Full Text] [Related]
10. [Systemic chemotherapy with high-dose cisplatin and sodium thiosulfate rescue].
Lee K; Kubota T; Yoshimine F; Sawamura M; Tsuchimoto K; Toyoda H; Miyagawa T; Kobayashi E; Kadowaki K; Kawamura E
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2391-4. PubMed ID: 3865635
[TBL] [Abstract][Full Text] [Related]
11. Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity.
Campbell AB; Kalman SM; Jacobs C
Cancer Treat Rep; 1983 Feb; 67(2):169-72. PubMed ID: 6681731
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of cisplatin in long-term hemodialysis treatment].
Sturn W; Sanwald R; Ehninger G
Dtsch Med Wochenschr; 1989 Mar; 114(9):337-9. PubMed ID: 2920679
[TBL] [Abstract][Full Text] [Related]
13. [A case of disappearance of peritoneal dissemination in gastric cancer induced by continuous hyperthermic peritoneal perfusion with cisplatin and mitomycin C].
Fujimura T; Yonemura Y; Urade M; Sugiyama K; Hasegawa H; Hashimoto T; Miyata R; Matsuda Y; Katayama K; Yamaguchi A
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2331-4. PubMed ID: 3136703
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
[TBL] [Abstract][Full Text] [Related]
15. [The protective effects of two hydration protocols against cisplatin nephrotoxicity].
Guo JH; Song ST; Xu ZL
Zhonghua Zhong Liu Za Zhi; 1994 Jan; 16(1):56-8. PubMed ID: 8033751
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic analysis in intraperitoneal hyperthermic chemotherapy of far-advanced gastric cancer patients.
Kobayashi K; Fujimoto S; Shrestha RD; Kokubun M; Kikuchi S; Konno C; Ohta M; Takahashi M; Okui K
Gan No Rinsho; 1989 Aug; 35(9):1016-20. PubMed ID: 2504971
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin nephrotoxicity. Correlation with plasma platinum concentrations.
Kelsen DP; Alcock N; Young CW
Am J Clin Oncol; 1985 Feb; 8(1):77-80. PubMed ID: 4039530
[TBL] [Abstract][Full Text] [Related]
18. [The pharmacokinetics of cisplatin and its influence on renal functions based on different infusion methods].
Takahashi A; Takagi M; Hishida H; Saji E; Takagi N; Amano H; Ogura Y
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2944-50. PubMed ID: 3116947
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics of cisplatin and vindesine in a patient with chronic renal failure undergoing hemodialysis].
Ayabe H; Uchikawa T; Kimino K; Tagawa Y; Kawahara K; Tomita M
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3283-5. PubMed ID: 2782920
[TBL] [Abstract][Full Text] [Related]
20. High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity.
Ostrow S; Egorin MJ; Hahn D; Markus S; Aisner J; Chang P; LeRoy A; Bachur NR; Wiernik PH
Cancer Treat Rep; 1981; 65(1-2):73-8. PubMed ID: 6784924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
